Agentix corrects prior filing; enters merger to make Applied BioPharma wholly-owned sub

Agentix Corp.

Corrects May 27, 2021 8-K to clarify Applied BioPharma was not then a wholly-owned subsidiary.
Enters Merger Agreement (July 13, 2021) with AB Merger LLC to acquire Applied BioPharma for 1 share of common stock.
Articles of Merger executed July 14, 2021, expected to be filed with Nevada Secretary of State on July 15, 2021.
Upon consummation, Applied BioPharma will become a wholly-owned subsidiary of Agentix Corp.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.